UNSPSC 51452503: Clofenotane

This classification denotes a pesticide and carcinogenic chlorinated hydrocarbon with the molecular formula C14H9Cl5, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier CIW5S16655, chemically known as 1,1,1-tricloro-2, 2-bis (4-cloro-fenil)-etano but more generally known as chlorophenothane, which bears U.S. NIH Compound Identifier 3036. European Medicines Agency schedules Clofenotane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06700MIG.

The term CHLOROPHENOTHANE is an International Non-Proprietary Name. World Health Organization schedules chlorophenothane in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 51452503 Clofenotane, a Commodity code, does not align with the pharmaceutical and medical-supply procurement activity appearing in recent state and local opportunities tagged under this code. The recent solicitations show state and local governments purchasing naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical supplies through direct procurement and cooperative purchasing vehicles—none of which relate to clofenotane, an insecticide with limited civilian application. The code exhibits a significant mismatch between its nominal scope (a single chemical product) and the actual work being solicited, suggesting either a classification error in the tagging of these opportunities or minimal legitimate activity under the code itself. State and local buyers issuing under this code include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), city fire and rescue departments (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government participants across multiple states including Oregon).

Recent opportunities show Seminole County, Florida issuing an IFB on June 30, 2026 (due July 26, 2023) for naloxone and drug deactivation systems; the Texas Health and Human Services Commission issuing an RFI on April 3, 2026 regarding direct-to-manufacturer prescription programs; the City of Tampa issuing a sheltered-market ITB on March 25, 2026 (due March 13, 2026) for medical and first aid supplies to the Fire Department Rescue Division at an estimated $700,000, reserved for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000; and the Minnesota Department of Administration issuing an RFP on January 20, 2026 (due March 26, 2026) through MMCAP for generic pharmaceuticals and OTC products across state and local members. Activity spans Florida, Texas, and Minnesota with cooperative-purchasing participation in Oregon. The code shows no recent solicitations for clofenotane itself and warrants verification of tagging accuracy before pursuing opportunities under it.